🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 5

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Sun, Mar 9, 2025 at 3:50 AM 44 replies 2,251 viewsPage 5 of 9
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
Mar 9, 2025 at 10:55 AM#21

Reading this thread on MASH prevalence in GLP-1 hits close to home. Night shift nurse — I started at 275 lbs and felt like I would tried everything.

11 months on tirz and I am a different person. Not just the 50 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about MASH prevalence in — take the leap. It was the best health decision I have ever made. ❤️

22 16RunnerRach, TrialNerd_Beth, HPLC_Greg and 19 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 9, 2025 at 11:12 AM#22

Moderator note: Reminder: nothing posted here constitutes medical advice. Consult your healthcare provider.

Tagging this for the weekly digest. 👍

Last edited: Mar 9, 2025 at 3:12 PM
37 18SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 34 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Mar 9, 2025 at 11:29 AM#23

Relevant to MASH prevalence in GLP-1 users — here is my latest bloodwork comparison:

Key improvements: A1C 8.0% → 5.3%, triglycerides 207 → 107 mg/dL, hsCRP 6.0 → 1.3 mg/L. All on tirzepatide for 11 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Last edited: Mar 9, 2025 at 1:29 PM
32 9LibrarianMeg, bri_stats, pete_manc_UK and 29 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Mar 9, 2025 at 11:46 AM#24

Thank you PharmacoVig_BOS! This is incredibly helpful. Bookmarking for later. 🙏

14 6nick_newbie, DadBodDave, AmyNC_wife and 11 others
Reply Quote Save Share Report
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Mar 9, 2025 at 12:03 PM#25

+1 to JenMemphis. Especially the point about "MASH prevalence in GLP-1 is exactly what..." — I have seen the same in my own experience with MASH prevalence in GLP-1.

16 12maria_elpaso, anders_CPH, Dr.NutriCornell and 13 others
Reply Quote Save Share Report
1345679

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register